Aquestive Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AQST and other ETFs, options, and stocks.About AQST
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz.
CEODaniel Barber
CEODaniel Barber
Employees142
Employees142
HeadquartersWarren, New Jersey
HeadquartersWarren, New Jersey
Founded2004
Founded2004
Employees142
Employees142
AQST Key Statistics
Market cap761.30M
Market cap761.30M
Price-Earnings ratio-8.87
Price-Earnings ratio-8.87
Dividend yield—
Dividend yield—
Average volume2.26M
Average volume2.26M
High today$6.36
High today$6.36
Low today$6.08
Low today$6.08
Open price$6.28
Open price$6.28
Volume1.82M
Volume1.82M
52 Week high$7.55
52 Week high$7.55
52 Week low$2.12
52 Week low$2.12
Stock Snapshot
As of today, Aquestive Therapeutics(AQST) shares are valued at $6.30. The company's market cap stands at 761.3M, with a P/E ratio of -8.87.
On 2026-01-07, Aquestive Therapeutics(AQST) stock moved within a range of $6.08 to $6.36. With shares now at $6.30, the stock is trading +3.6% above its intraday low and -0.9% below the session's peak.
Trading activity shows a volume of 1.82M, compared to an average daily volume of 2.26M.
Over the past 52 weeks, Aquestive Therapeutics(AQST) stock has traded between a high of $7.55 and a low of $2.12.
Over the past 52 weeks, Aquestive Therapeutics(AQST) stock has traded between a high of $7.55 and a low of $2.12.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own AQST. This list is generated using Robinhood data, and it’s not a recommendation.